Q3 2019 13F Holders as of 30 Sep 2019
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
54,689,892
-
Share change
-
-4,178,086
-
Total reported value
-
$156,984,254
-
Put/Call ratio
-
174%
-
Price per share
-
$2.87
-
Number of holders
-
141
-
Value change
-
-$28,662,955
-
Number of buys
-
73
-
Number of sells
-
70
Institutional Holders of ACORDA THERAPEUTICS INC - COM (ACOR) as of Q3 2019
As of 30 Sep 2019,
ACORDA THERAPEUTICS INC - COM (ACOR) was held by
141 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
54,689,892 shares.
The largest 10 holders included
BlackRock Inc., FMR LLC, VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, DIMENSIONAL FUND ADVISORS LP, SCOPIA CAPITAL MANAGEMENT LP, BAKER BROS. ADVISORS LP, Partner Fund Management, L.P., ACADIAN ASSET MANAGEMENT LLC, and STATE STREET CORP.
This page lists
141
institutional shareholders reporting positions in this security
for the Q3 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.